4-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine hydrochloride, 95%, 1g

4'-Benzyloxyphenyl acetylene, 98.0%, 250mg

(R)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 10g

5-Methyloxazole, 95.0%, 5g

2-Fluoro-3-nitrobenzonitrile, 95.0%, 10g

2-Amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 2.5g

4-Propylcyclohexanecarboxylic Acid (cis- and trans- mixture)>98.0%(GC)(T)25g

2-Fluoro-4-(trifluoromethyl)benzylamine, 97.0%, 250mg

1-AZETIDIN-1-YL-2-CHLORO-ETHANONE, 95.0%, 5g

2-(Oxazol-4-yl)phenol, 250mg

5-Chloro-[1,1'-biphenyl]-2-amine, 95.0%, 1g

EDTA sale bisodico di rame x H2O, minimo 99%, per sintesi, 250 g, confezione in plastica.

6,8-dichloro-7H-purin-2-amine, 97%, 250mg